Screening for clinical insomnia in cancer patients with the Edmonton Symptom Assessment System-Revised: a specific sleep item is needed
We previously investigated the capacity of the original version of the Edmonton Symptom Assessment System-Revised (ESAS-r) and the Canadian Problem Checklist (CPP) to screen for clinical levels of insomnia in cancer patients. The original ESAS-r includes an item assessing drowsiness and an “other symptom” item, both of which are rated on a scale from 0 to 10, while the CPC has a sleep item, a box which is checked when this problem is present. Because none of these items showed an optimal screening capacity, we concluded that it would be best to add a specific 0–10 sleep item to the ESAS-r. This study assessed the capacity of this ESAS-r-sleep item to screen for clinical insomnia in patients with various cancer types.
A total of 392 patients with mixed cancer sites completed the ESAS-r as part of a routine screening procedure implemented in the radio-oncology department of L’Hôtel-Dieu de Québec (CHU de Québec-Université Laval). They also filled out the Insomnia Severity Index (ISI).
Using a score of 8 or greater on the ISI as the standard criterion for clinical insomnia, a score of 2 or higher on the ESAS-r-sleep item (50.8% of the patients) was the one that showed the best screening indices: sensitivity of 86.7%, specificity of 75.3%, positive predictive value of 71.9%, and negative predictive value of 88.6%. An area under the curve of 0.89 was found, which is excellent.
Adding a sleep item to the ESAS significantly improves screening of clinical insomnia in cancer patients.
KeywordsInsomnia Sleep Screening Tiredness Fatigue Cancer ROC
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Cleeland CS, Zhao F, Chang VT, Sloan JA, O’Mara AM, Gilman PB, Weiss M, Mendoza TR, Lee JW, Fisch MJ (2013) The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer 119:4333–4340. https://doi.org/10.1002/cncr.28376 CrossRefPubMedGoogle Scholar
- 4.Ataseven B, Findte J, Harter P, Göke G, Holtschmidt J, Vogi C, Traut A, Vincenzo B, Vincent M, Florian H, Kuemmel S, Prader S, Sporkman M, Schneider S, du Bois A (2017) Change of patient perceptions of chemotherapy side effects in breast and ovarian cancer patients. Annueal conference of the European Society for Medical OncologyGoogle Scholar
- 13.Travado L, Breitbart W, Grassi L, Fujisawa D, Patenaude A, Baider L, Connor S, Fingeret M (2017) 2015 President’s Plenary International Psycho-oncology Society: psychosocial care as a human rights issue-challenges and opportunities. Psychooncology 26:563–569. https://doi.org/10.1002/pon.4209 CrossRefPubMedGoogle Scholar
- 16.Fitch MI, Porter HB, Page BD (2008) Supportive care framework: a foundation for person-centered care. Pappin Communications Pembroke. https://books.google.ca/books/about/Supportive_Care_Framework.html?id=WoI9twAACAAJ&redir_esc=y. Accessed 1 July 2018
- 19.Howell D, Oliver TK, Keller-Olaman S, Davidson J, Garland S., Savard J, Harris C, Aubin M, Olson K, Sussman J, Macfarlane J, Taylor C and the Sleep Disturbance Expert Panel on behalf of the Cancer Journey Advisory Group of the Canadian Partnership Against Cancer (2012) A pan-Canadian practice guideline: prevention, screening, assessment, and treatment of sleep disturbances in adults with cancer. Support Care Cancer 21:2695–2706Google Scholar
- 25.Bernatchez MS, Savard J, Savard MH, Aubon M and Ivers H (in press) Sleep-wake difficulties in community-dwelling cancer patients receiving palliative care: Subjective and objective assessment. Palliat Support Care 1–11. https://doi.org/10.1017/S1478951517000815